| Original language | English |
|---|---|
| Pages (from-to) | 691 |
| Journal | European Journal of Heart Failure |
| Volume | 19 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - May 1 2017 |
Cite this
Is sildenafil neutral on cardiopulmonary performance in group 2 pulmonary hypertension? More details for interpretation. / Guazzi, Marco.
In: European Journal of Heart Failure, Vol. 19, No. 5, 01.05.2017, p. 691.Research output: Contribution to journal › Letter
@article{260a70f657c342bd8b8cfa379520e9a5,
title = "Is sildenafil neutral on cardiopulmonary performance in group 2 pulmonary hypertension? More details for interpretation",
author = "Marco Guazzi",
year = "2017",
month = "5",
day = "1",
doi = "10.1002/ejhf.753",
language = "English",
volume = "19",
pages = "691",
journal = "European Journal of Heart Failure",
issn = "1388-9842",
publisher = "John Wiley & Sons, Ltd",
number = "5",
}
TY - JOUR
T1 - Is sildenafil neutral on cardiopulmonary performance in group 2 pulmonary hypertension? More details for interpretation
AU - Guazzi, Marco
PY - 2017/5/1
Y1 - 2017/5/1
UR - http://www.scopus.com/inward/record.url?scp=85011117665&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85011117665&partnerID=8YFLogxK
U2 - 10.1002/ejhf.753
DO - 10.1002/ejhf.753
M3 - Letter
AN - SCOPUS:85011117665
VL - 19
SP - 691
JO - European Journal of Heart Failure
JF - European Journal of Heart Failure
SN - 1388-9842
IS - 5
ER -